# | Title | Journal | Year | Citations |
---|
1 | Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma | Cancer | 2015 | 447 |
2 | LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems | Journal of Clinical Investigation | 2007 | 440 |
3 | PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival | Cancer Immunology Research | 2013 | 333 |
4 | Tumor-Initiating Cells Are Rare in Many Human Tumors | Cell Stem Cell | 2010 | 205 |
5 | Melanoma subtypes demonstrate distinct PD-L1 expression profiles | Laboratory Investigation | 2017 | 156 |
6 | Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 145 |
7 | The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma | Cancer Immunology Research | 2016 | 133 |
8 | Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 124 |
9 | Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade | | 2017 | 118 |
10 | Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells | ACS Applied Materials & Interfaces | 2019 | 98 |
11 | An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy | Cancer | 2012 | 91 |
12 | Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting | Journal of Translational Medicine | 2015 | 84 |
13 | Cancer spectrum and outcomes in the Mendelian short telomere syndromes | Blood | 2020 | 79 |
14 | Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships | Journal of Radiation Oncology | 2013 | 74 |
15 | Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy | Clinical Cancer Research | 2017 | 67 |
16 | The Diagnosis and Surgical Treatment of Pancreatoblastoma in Adults: A Case Series and Review of the Literature | Journal of Gastrointestinal Surgery | 2013 | 52 |
17 | Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides | American Journal of Clinical Pathology | 2017 | 52 |
18 | PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation | Cancer Immunology Research | 2015 | 45 |
19 | Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells | Journal of Biological Chemistry | 2016 | 45 |
20 | Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming | Nature Communications | 2020 | 45 |
21 | Force-dependent extracellular matrix remodeling by early-stage cancer cells alters diffusion and induces carcinoma-associated fibroblasts | Biomaterials | 2020 | 44 |
22 | Inflammation, Microbiota, and Prostate Cancer | European Urology Focus | 2016 | 40 |
23 | Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden | Blood Advances | 2020 | 37 |
24 | Long Interspersed Nuclear Element 1 Retrotransposons Become Deregulated during the Development of Ovarian Cancer Precursor Lesions | American Journal of Pathology | 2019 | 35 |
25 | Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions | Transfusion | 2012 | 34 |
26 | Pancreatic Neoplasms With Acinar Differentiation: A Review of Pathologic and Molecular Features | Archives of Pathology and Laboratory Medicine | 2020 | 31 |
27 | Pancreatic cancer: a growing burden | The Lancet Gastroenterology and Hepatology | 2019 | 29 |
28 | Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis | Diagnostic and Interventional Imaging | 2020 | 29 |
29 | Induction of spermidine/spermine N 1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N 1,N 11-diethylnorspermine | Cancer Chemotherapy and Pharmacology | 2004 | 27 |
30 | Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: Implications for radiation therapy planning | Radiotherapy and Oncology | 2012 | 27 |
31 | Diagnostic utility of 5‐hydroxymethylcytosine immunohistochemistry in melanocytic proliferations | Journal of Cutaneous Pathology | 2015 | 26 |
32 | Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association | Modern Pathology | 2018 | 24 |
33 | Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration | British Journal of Cancer | 2011 | 23 |
34 | TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target | Journal of Pathology | 2019 | 23 |
35 | The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? | Leukemia and Lymphoma | 2015 | 20 |
36 | P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer | Journal of Pathology | 2022 | 16 |
37 | Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma | Blood | 2022 | 15 |
38 | Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer | International Journal of Surgical Oncology | 2012 | 13 |
39 | Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes | Journal of Pathology | 2021 | 13 |
40 | The “Infectious” Nature of Human Prostate Cancer: A Cautionary Note | Oncotarget | 2011 | 12 |
41 | Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum | Ocular Oncology and Pathology | 2016 | 10 |
42 | Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases | Molecular Oncology | 2021 | 10 |
43 | Malignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation | Journal of Neuropathology and Experimental Neurology | 2018 | 9 |
44 | Phenotypic characterization of two novel cell line models of castration‐resistant prostate cancer | Prostate | 2021 | 9 |
45 | Analysis of Polymorphisms and Haplotype Structure of the Human Thymidylate Synthase Genetic Region: A Tool for Pharmacogenetic Studies | PLoS ONE | 2012 | 8 |
46 | Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) | Leukemia Research | 2014 | 8 |
47 | Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia | European Urology | 2016 | 8 |
48 | TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma | Cancer Letters | 2021 | 5 |
49 | Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting | Journal of Cancer Prevention | 2021 | 4 |
50 | Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma | ELife | 2022 | 4 |